It is also important to further understand the risk of other cancers (in addition to breast cancer) that are associated with pathogenic variants in CHEK2 that include cancers in the Li-Fraumeni syndrome spectrum [35] and prostate cancer [36] and the associated penetrance of CHEK2 pathogenic variants for these cancers. This evidence concerns the gene CHEK2 and breast carcinoma.